Director, Commercial Training
Who We Are:
Cogent Biosciences is a publicly traded biotechnology company dedicated to developing precision therapies for genetically defined diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease and offer meaningful hope to patient's.
The company’s lead therapeutic candidate, bezuclastinib, is a highly selective tyrosine kinase inhibitor designed to potently target KIT D816V and other mutations in KIT exon 17. These mutations are known drivers of systemic mastocytosis (SM) and advanced gastrointestinal stromal tumors (GIST) - both serious conditions driven by oncogenic KIT signaling. Bezuclastinib is currently being evaluated in multiple registration-directed trials across Non-Advanced SM (NonAdvSM), Advanced SM (AdvSM), and GIST. In July 2025, Cogent announced that its registration-direct SUMMIT trial in patients with NonAdvSM achieved statistical significance across all primary and key secondary endpoints, and the company is on track to file its first New Drug Application for this patient population by the end of 2025. The company also remains on track to announce top-line results for its APEX trial in patients with AdvSM in the second half of 2025 and for its PEAK trial in patients with GIST by the end of 2025. The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor, and the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting other serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
Through its commitment to precision medicine and targeted innovation, Cogent Biosciences is working to transform the treatment landscape for patients with serious and underserved diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create real solutions that address the underlying drivers of disease. Our culture of inquisitiveness fuels continuous learning and innovation; we challenge assumptions, ask bold questions, and embrace a mindset of discovery to uncover transformative insights.
The Role:
- Act as the key strategic advisor to senior commercial leadership on ensuring the executional readiness and continuous improvement of the commercial organization to effectively launch Cogent Biosciences’ first product, bezuclastinib.
- Design and implement comprehensive training strategies to support product launches, including rare disease and specialty therapeutics.
- Develop and deliver sales training programs covering disease state education, product knowledge, selling skills, and digital tools.
- Lead instructional design efforts, integrating adult learning principles and innovative modalities (e.g., virtual, in-person, microlearning).
- Manage Learning Management System (LMS) content and ensure seamless delivery and tracking of training initiatives.
- Collaborate cross-functionally with Sales, Marketing, Medical Affairs, Market Access, Compliance, and HR to align training with business objectives.
- Develop the training plan in integrating new systems, processes, platforms or ways of working for the commercial teams (ex: new CRM features or capabilities).
- Establish performance metrics and feedback loops to measure training effectiveness and field readiness.
- Elevate L&D planning by identifying gaps, provide recommendations and implement a plan that will enhance current capabilities for the future.
- Oversee vendor relationships and budget planning for external training partners and resources.
- Support POA meetings, field communications, and continuous learning initiatives.
Qualifications:
- Bachelor’s degree in Life Sciences, Business, Education, or related field; advanced degree preferred.
- 8+ years of experience in pharmaceutical or biotech industry, with a focus on commercial training and learning & development.
- Proven experience in launch readiness and sales force enablement in rare disease, oncology, or specialty therapeutics.
- Ability to set priorities, deliver on deadlines and develop workflow processes and tasks in an evolving, dynamic marketplace.
- Strong analytical skills and budget management.
- Ability to design and deliver tailored strategies and frameworks to a diverse set of stakeholders.
- Expertise in instructional design, adult learning principles, and LMS platforms.
- Strong project management, communication, and cross-functional collaboration skills.
- Ability to analyze performance data and translate insights into actionable training improvements.
- Experience managing vendors and training budgets.
Salary Range:
210,000 - 240,000 $USD
Apply for this job
*
indicates a required field